Daughter now as about 75K on her car.. I was told du to all the miles she puts on a car she ought to LEASE one.. Get a new one every year
OK I’m asking tell me the pro’s and con’s on this
OK I’m asking tell me the pro’s and con’s on this
It was only three years ago that Kia brought out its first mid-size crossover utility vehicle, the Sorento, and now Kia has made significant changes such as new refined styling, a new V6 engine, an improved chassis/suspension, comfort and convenience upgrades that make the all-new Sorento more enjoyable to drive and to be a passenger(s).
The new engine is a 3.3 liter all-aluminum DOHC V6 with dual CVVT and gasoline direct injection (GDI). It pumps out a healthy 290hp at 6,400rpm and 252lb.ft. of torque at 5,200rpm. Power is routed to either the front wheels or, optionally, to all four wheels using an enhanced Torque On Demand and all-wheel drive system that seamlessly directs power to the tire with the most traction and now includes the benefit of Torque Vectoring Cornering Control (TVCC) that aids stability under several driving conditions. The smooth shifting six-speed automatic OD transmission is standard and comes with Kia’s Sportmatic Sequential shifting capability that enabled me to keep the transmission in a gear all the up to redline for a more spirited driving experience. Power delivery is strong and steady, especially when I was merging onto fast moving highway traffic. Also standard in the 2014 edition is an Electric Motor Driven Power Steering system that replaces the hydraulic unit from last year’s model. It has improved efficiency and is quicker with 2.95 turns of the steering wheel, lock-to-lock. This new system also features an optional Flex Steer system that offers a choice of three steering modes: Comfort, Normal and Sport. It is a terrific system that lets me choose how fast I want my steering inputs to play with the current driving situation. I choose normal for everyday driving or Sport when I wanted to take on some steep curving roads.
Just three years into its product lifecycle, Kia’s engineers saw fit to bring the new 2014 Sorento to market on an all-new chassis that increases torsional rigidity by 18%. A major focal point in designing the new chassis was to improve ride and handling. Within the engine bay, strut-tower bracing increases chassis strength and provides a solid platform for the redesigned independent MacPherson strut setup with coil springs, new dual-flow gas-charged shocks and a stabilizer bar, that is mounted to a stiffer H-shaped subframe cradle for improved ride comfort, handling prowess and NVH (Noise, Vibration, Harshness). In the rear a reinforced multi-link setup includes coil springs, dual-path gas-charged shocks and a stabilizer bar. It also includes new, larger bushings and mounts to improve road noise, vibration and straight line stability at high speeds while its compact design allows for more interior space. The new front and rear suspension geometry really can be felt by how well the 19X7.5 inch alloy wheels wrapped with new larger 235/55R19 inch tires that grip the road …read more
Did rehab actually make Cory Monteith more vulnerable? Doctors explain to USA Today that drug users can be at higher risk of overdosing after leaving rehab if they aren’t able to stay clean. Because heroin users build up a tolerance to the drug— which contributed to Monteith’s death —they have… …read more
Source: FULL ARTICLE at Newser – Home
Police have charged a man and his mother with endangering a 10-year-old boy who called 911 when they passed out at home while allegedly using heroin.
The Beaver County Times (http://bit.ly/ZP7FBB ) reports police found both adults unresponsive when they arrived Friday evening.
Online court records don’t list attorneys for 34-year-old Chad Kiser and 52-year-old Ginger Ray Foust of New Brighton. The boy is Kiser’s son and Foust’s grandson.
Kiser and Foust were charged with possessing drug paraphernalia and endangering the welfare of the boy, who told police that his grandmother went into the bathroom to help his father after he passed out. The boy told police each adult was trying to help the other battle a drug addiction.
The boy has been placed in county welfare custody.
Information from: Beaver County Times, http://www.timesonline.com/
Filed under: Investing
New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure.
Primary Composite Efficacy Endpoint Met in REMINDER trial
SAN FRANCISCO–(BUSINESS WIRE)– Pfizer Inc. (NYS: PFE) today announced results from the REMINDER trial showing statistically significant risk reductions in the primary composite efficacy endpoint. The composite endpoint was defined as the time to first event of cardiovascular (CV) mortality, re-hospitalization or extended initial hospital stay due to diagnosis of heart failure (HF), sustained ventricular tachycardia or fibrillation, ejection fraction (EF) ≤40% after 1 month, or an elevation of BNP/ NT-proBNP after 1 month.
The results were presented for the first time during the Late Breaker Clinical Trial session at the 62nd Annual Scientific Session of the American College of Cardiology in San Francisco today.
The REMINDER trial was a randomized, double-blind trial, involving 1,012 patients with acute ST-segment elevation myocardial infarction (STEMI) without a history of HF or EF <40% and without signs of HF. Patients received, preferably before myocardial reperfusion, either eplerenone (25-50 mg OD) or placebo in addition to standard therapy. Treatment was initiated within the first 24 hours of symptom onset (preferably within first 12h).
The REMINDERtrial demonstrated a statistically significant 42.9% relative risk reduction in the primary endpoint with p < 0.0001 (95% confidence interval [CI] 0.439, 0.742) in patients with acute STEMI when eplerenone was initiated within the first 24 hours of onset of symptoms. Overall, the adverse events reported in the REMINDER trial were consistent with those already known for eplerenone, primarily hyperkalemia.
Eplerenone is not approved for use in the patient population studied in the REMINDER trial in any market.
The improvement in outcome was mainly driven by a significant reduction of the BNP / NT-proBNP biomarker component at 1 month. BNP/NT-proBNP has been shown to be an important marker for short- and long-term prognosis in patients with myocardial infarction in the presence or absence of preserved ejection fraction. An elevation of BNP / NT-proBNP after 1 month was observed less frequently in the eplerenone group 81(16.0%) than in the placebo group 131(25.9%) (adjusted HR, …read more
Source: FULL ARTICLE at DailyFinance
Alec Baldwin used the “C-Word!” Will Obama and the Congressional Black Caucus ignore daily urban fratricide to banish him from Hollyweird liberaldom?
It warms my heart to see a high-profile member of the so-called “party of the little man” show just how little he always thought of the little man.
If true, don’t expect the pigmentary politburo ruling my figurative side of town (Black America) to fall over themselves chastising him.
I wonder what Baldwin’s lame excuse will be for this tirade, while worried millions of dollars may possibly slip through his fingers?
At day’s end (and I could be grievously wrong), nothing will happen because he’s a Hollyweird Democrat, and the mainstream media would have to demonstrate rare integrity to punish him on the merits of this allegation.
If he did deploy the “C-Word”, he quoted from the old school Democrat handbook on what to call Black folks.
Way to go, Alec!
To quote a civil rights activist, Jesse Jackson, who may be allowed to address this case, “Keep Hope Alive!”
Donate/Stop Socialist Hate: http://www.gofundme.com/197xk8
Photo credit: david_shankbone (Creative Commons)